Weber, F.; Eichner, H.; Cuntz, H.; Borst, A.: Eigenanalysis of a neural network for optic flow processing. New Journal of Physics 10, 015013 (2008)

Löw, K.; Culbertson, M.; Bradke, F.; Tessier-Lavigne, M.; Tuszynski, M.: Netrin-1 is a novel myelin-associated inhibitor to axon growth. The Journal of Neuroscience 28 (5), pp. 1099 - 1108 (2008)

Macke, J. H.; Maack, N.; Gupta, R.; Denk, W.; Schölkopf, B.; Borst, A.: Contour-propagation algorithms for semi-automated reconstruction of neural processes. Journal of Neuroscience Methods 167 (2), pp. 349 - 357 (2008)

Kuhl, A.; Melberg, A.; Meinl, E.; Nürnberg, G.; Nürnberg, P.; Kehrer-Sawatzki, H.; Jenne, D. E.: Myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7: Corroboration and narrowing of the critical region on 10q22.3. European Journal of Human Genetics 16, pp. 367 - 373 (2008)

Becker, K.; Jahrling, N.; Kramer, E. R.; Schnorrer, F.; Dodt, H. U.: Ultramicroscopy: 3D reconstruction of large microscopical specimens. Journal of Biophotonics 1 (1), pp. 36 - 42 (2008)

Derfuss, T.; Direskeneli, G. S.; Hohlfeld, R.; Meinl, E.: Autoantigen- und erregerspezifische T- und B-Zellreaktionen bei multipler Sklerose: „Eine unendliche Geschichte”? Aktuelle Neurologie 35 (7), pp. 345 - 355 (2008)

Haghikia, A.; Fischer, M.; Hellwig, K.; Linker, R.; Chan, A.; Hohlfeld, R.; Gold, R.: Open use of natalizumab. Neutralising antibodies and clinical data. Nervenarzt 79 (6), pp. 716 - 719 (2008)

Hoffmann, L. A.; Lohse, P.; König, F. B.; Feneberg, W.; Hohlfeld, R.; Kümpfel, T.: TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome. Neurology 70 (13 Pt 2), pp. 1155 - 1156 (2008)

Jarius, S.; Paul, F.; Franciotta, D.; Waters, P.; Zipp, F.; Hohlfeld, R.; Vincent, A.; Wildemann, B.: Mechanisms of disease: Aquaporin-4 antibodies in neuromyelitis optica. Nature Clinical Practice Neurology 4 (4), pp. 202 - 214 (2008)

Kessenbrock, K.; Fröhlich, L.; Sixt, M.; Lämmermann, T.; Pfister, H.; Bateman, A.; Belaaouaj, A.; Ring, J.; Ollert, M.; Fässler, R. et al.; Jenne, D. E.: Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. Journal of Clinical Investigation 118 (7), pp. 2438 - 2447 (2008)

Kümpfel, T.; Hoffmann, L. A.; Pellkofer, H.; Pöllmann, W.; Feneberg, W.; Hohlfeld, R.; Lohse, P.: Multiple sclerosis and the TNFRSF1A R92Q mutation: Clinical characteristics of 21 cases. Neurology 71, pp. 1812 - 1820 (2008)

Obermeier, B.; Malotka, J.; Dornmair, K.; Mentele, R.: Analysis of patient-specific immunoglobulin proteomes and transcriptomes by PCR cloning and mass spectometry. (2008)

Riedl, J.; Crevenna, A. H.; Kessenbrock, K.; Yu, J. H.; Neukirchen, D.; Bista, M.; Bradke, F.; Jenne, D. E.; Holak, T. A.; Werb, Z. et al.; Sixt, M.; Wedlich-Söldner, R.: Lifeact: A versatile marker to visualize F-actin. Nature Methods 5 (7), pp. 605 - 607 (2008)

Sommer, N.; Tackenberg, B.; Hohlfeld, R.: The immunopathogenesis of myasthenia gravis. Handb Clin Neurol 91 (Chapter 5), pp. 169 - 212 (2008)

Theil, D. J.; Libbey, J. E.; Rodriguez, F.; Whitton, J. L.; Tsunoda, I.; Derfuss, T.; Fujinami, R. S.: Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 204 (1-2), pp. 92 - 100 (2008)

Wiendl, H.; Toyka, K. V.; Rieckmann, P.; Gold, R.; Hartung, H. P.; Hohlfeld, R.: Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations. Journal of Neurology 255 (10), pp. 1449 - 1463 (2008)

Boeda, B.; Briggs, D. C.; Higgins, T.; Garvalov, B. K.; Fadden, A. J.; McDonald, N. Q.; Way, M.: Tes, a specific Mena interacting partner, breaks the rules for EVH1 binding. Molecular Cell 28 (6), pp. 1071 - 1082 (2007)

Hajjar, E.; Korkmaz, B.; Reuter, N.: Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase. FEBS Letters 581 (29), pp. 5685 - 5690 (2007)

Kowsky, S.; Poppelmeyer, C.; Kramer, E. R.; Falkenburger, B. H.; Kruse, A.; Klein, R.; Schulz, J. B.: RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals. Proceedings of the National Academy of Sciences of the United States of America 104 (50), pp. 20049 - 20054 (2007)

Grundtner, R.; Dornmair, K.; Dahm, R.; Flügel, A.; Kawakami, N.; Zeitelhofer, M.; Schoderboeck, L.; Nosov, M.; Selzer, E.; Willheim, M. et al.; Kiebler, M.; Wekerle, H.; Lassmann, H.; Bradl, M.: Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system. Neurobiology of Disease 28 (3), pp. 261 - 275 (2007)